EUVIMEDEUVIMED entdecken
Crossref

HLA-B*57:01 Typing in a Malaysian Cohort: Implications of Abacavir Hypersensitivity in People Living with HIV

V Kalidasan iD, Iswarya Kunalan, Reena Rajasuriar iD, Vijay Kumar Subbiah iD, Kumitaa Theva Das iD

Pharmacogenomics · 2023

DOI: 10.2217/pgs-2023-0136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacogenomics, 2023. Verfasst von V Kalidasan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Advanced Medical and Dental Institute, Universiti Sains Malaysia, 13200, Kepala Batas, Penang, Malaysia. Hauptthemen laut MEDLINE: HLA-B Antigens, Dideoxynucleosides, HIV Infections, Drug Hypersensitivity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Universiti Sains Malaysia, Ministry of Higher Education, Malaysia, KT’s grants – Universiti Sains Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Abacavir (ABC) in combination with other antiretroviral drugs, is used to treat people living with HIV (PLWH). However, it is linked to a fatal hypersensitivity reaction in susceptible individuals, and is strongly associated with the HLA-B*57:01 allele. Materials & methods: A total of 152 patients, 50 PLWH and 102 HIV-1 negative patients, were assessed for the HLA-B*57:01 allele through a sequence-specific primer PCR.

Results

All PLWH tested negative for the HLA-B*57:01 allele, but two HIV-negative patients were found to have HLA-B*57, with one of them expressing the HLA-B*57:01 allele.

Conclusion

Given the low prevalence of this risk allele in the population, testing for the presence of HLA-B*57:01 in PLWH may not provide significant benefit for the reported population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HLA-B AntigensDideoxynucleosidesHIV InfectionsDrug HypersensitivityAnti-HIV AgentsHumansMaleFemaleMalaysiaAdultMiddle AgedCohort StudiesAlleles

Stichwörter der Autor:innen

HIVHLA-B*57:01Malaysiaabacavirhypersensitivity reaction

Substanzen

HLA-B AntigensDideoxynucleosidesAnti-HIV AgentsHLA-B*57:01 antigenHLA-B57 antigen

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Advanced Medical and Dental Institute, Universiti Sains Malaysia, 13200, Kepala Batas, Penang, Malaysia.
  • School of Biological Sciences, Universiti Sains Malaysia, 11700, Gelugor, Penang, Malaysia.
  • Department of Medicine, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
  • Centre of Excellence Research in AIDS (CERiA), Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.
  • Biotechnology Research Institute, Universiti Malaysia Sabah, 88400, Kota Kinabalu, Sabah, Malaysia.

ORCID-Profile: V Kalidasan, Reena Rajasuriar, Vijay Kumar Subbiah, Kumitaa Theva Das

Förderung

  • Universiti Sains Malaysia
  • Ministry of Higher Education, Malaysia
  • KT’s grants – Universiti Sains Malaysia

Zitieren

APA

Kalidasan, V., Kunalan, I., Rajasuriar, R., Subbiah, V. K., & Das, K. T. (2023). HLA-B*57:01 Typing in a Malaysian Cohort: Implications of Abacavir Hypersensitivity in People Living with HIV. Pharmacogenomics. https://doi.org/10.2217/pgs-2023-0136

Vancouver

Kalidasan V, Kunalan I, Rajasuriar R, Subbiah VK, Das KT. HLA-B*57:01 Typing in a Malaysian Cohort: Implications of Abacavir Hypersensitivity in People Living with HIV. Pharmacogenomics. 2023. doi:10.2217/pgs-2023-0136

BibTeX
@article{Kalidasan2023,
  author = {Kalidasan, V and Kunalan, Iswarya and Rajasuriar, Reena and Subbiah, Vijay Kumar and Das, Kumitaa Theva},
  title = {HLA-B*57:01 Typing in a Malaysian Cohort: Implications of Abacavir Hypersensitivity in People Living with HIV},
  journal = {Pharmacogenomics},
  year = {2023},
  doi = {10.2217/pgs-2023-0136}
}
Kostenlos starten →